Trade Mark Journal No.2025/030 25 July 2025

UK00004228093 2 July 2025 (5,42)

RYCARMA

International priority date claimed: 17 January 2025 (United States of America) (99006283)

Class 5: Pharmaceutical preparations for that restoring normal intracellular calcium regulation; Chemical preparations for pharmaceutical or medical purposes, namely, for restoring normal intracellular calcium regulation; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; a full line of medicinal and pharmaceutical preparations; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders.
Class 42: Pharmaceutical research and development.

RyCarma Therapeutics, Inc.

Representative: Mishcon de Reya LLP